Discovery & Innovation

Producing High-Quality Antibodies

Public-Private Partnerships (PPPs) for Drug Discovery

Using Directed Evolution in the Lab

Virtual Drug Discovery: Publishing

Virtual Drug Discovery: Finding Service Providers

Virtual Drug Discovery: Online Sources of Funding

Improving Translational Decision-Making through Disease-Relevant Preclinical Models in Pulmonary Fibrosis and Pain Drug Discovery

New Approach Methodologies (NAMs): Key Considerations and Applications

Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research

Building New Approach Methodologies (NAMs) and Complex In Vitro Assays

Closing Gaps in Care: Health Equity and the Inflation Reduction Act - A Cutting Edge Conversation

Addressing Orphan and Rare Diseases - A Cutting Edge Conversation

Cutting Edge Conversations: Fighting Neurodegenerative Diseases

Cutting Edge Conversations: Discovering New Innovations in Oncology

Cutting Edge Conversations: Addressing COVID-19 During Uncertainty

Cutting Edge Conversations: Addressing Orphan and Rare Diseases

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Marketplaces Drive Faster Science: HEOR, RWE & Market Access Sourcing

Cutting Edge Conversations: Fighting Neurodegenerative Diseases

Cutting Edge Conversations: Discovering New Innovations in Oncology

Cutting Edge Conversations: Addressing COVID-19 During Uncertainty

Cutting Edge Conversations: Finding Solutions to the Obesity Epidemic

Cutting Edge Conversations: Biomarkers - Challenges and Opportunities

Cutting Edge Conversations: Innovative Approaches to Chemistry, Manufacturing and Controls

Cutting Edge Conversations: Challenges in Sourcing Human Biosamples

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Cutting Edge Conversations: Value, Access and Evidence - Biotech Market Access

Cutting Edge Conversations: The Role of In Vivo Studies in Personalized Medicine